Enhanced efficiency of human pluripotent stem cell genome editing through replacing TALENs with CRISPRs.
作者信息
Ding Qiurong, Regan Stephanie N, Xia Yulei, Oostrom Leoníe A, Cowan Chad A, Musunuru Kiran
出版信息
Cell Stem Cell. 2013 Apr 4;12(4):393-4. doi: 10.1016/j.stem.2013.03.006.
Abstract
摘要
相似文献
1
Enhanced efficiency of human pluripotent stem cell genome editing through replacing TALENs with CRISPRs.
Cell Stem Cell. 2013 Apr 4;12(4):393-4. doi: 10.1016/j.stem.2013.03.006.
2
TALEN- and CRISPR/Cas9-Mediated Gene Editing in Human Pluripotent Stem Cells Using Lipid-Based Transfection.
Curr Protoc Stem Cell Biol. 2015 Aug 3;34:5B.3.1-5B.3.25. doi: 10.1002/9780470151808.sc05b03s34.
3
Genome Editing in Human Pluripotent Stem Cells: Approaches, Pitfalls, and Solutions.
Cell Stem Cell. 2016 Jan 7;18(1):53-65. doi: 10.1016/j.stem.2015.12.002.
4
Low-Dose Irradiation Enhances Gene Targeting in Human Pluripotent Stem Cells.
Stem Cells Transl Med. 2015 Sep;4(9):998-1010. doi: 10.5966/sctm.2015-0050. Epub 2015 Jul 16.
5
Genome editing in pluripotent stem cells: research and therapeutic applications.
Biochem Biophys Res Commun. 2016 May 6;473(3):665-74. doi: 10.1016/j.bbrc.2016.02.113. Epub 2016 Feb 27.
6
Transcription activator-like effector nucleases (TALENs): a highly efficient and versatile tool for genome editing.
Biotechnol Bioeng. 2013 Jul;110(7):1811-21. doi: 10.1002/bit.24890. Epub 2013 Apr 7.
7
Genome editing of human pluripotent stem cells to generate human cellular disease models.
Dis Model Mech. 2013 Jul;6(4):896-904. doi: 10.1242/dmm.012054. Epub 2013 Jun 10.
8
Genome Editing of Lineage Determinants in Human Pluripotent Stem Cells Reveals Mechanisms of Pancreatic Development and Diabetes.
Cell Stem Cell. 2016 Jun 2;18(6):755-768. doi: 10.1016/j.stem.2016.03.015. Epub 2016 Apr 28.
9
Genome Editing in Human Pluripotent Stem Cells.
Methods Mol Biol. 2017;1590:165-174. doi: 10.1007/978-1-4939-6921-0_12.
10
Generation of gene-modified mice via Cas9/RNA-mediated gene targeting.
Cell Res. 2013 May;23(5):720-3. doi: 10.1038/cr.2013.46. Epub 2013 Apr 2.
引用本文的文献
1
Advancements in CRISPR-Cas Systems for Genome Editing towards Eradication of Human Microbial Pathogens.
Mol Biotechnol. 2025 Aug 20. doi: 10.1007/s12033-025-01482-w.
2
Multi-species analysis of inflammatory response elements reveals ancient and lineage-specific contributions of transposable elements to NF-kB binding.
Genome Res. 2025 Jul 1;35(7):1544-1559. doi: 10.1101/gr.280357.124.
3
Leveraging CRISPR activation for rapid assessment of gene editing products in human pluripotent stem cells.
Stem Cell Reports. 2025 Jun 10;20(6):102499. doi: 10.1016/j.stemcr.2025.102499. Epub 2025 May 8.
4
Intelligent Manufacturing for Osteoarthritis Organoids.
Cell Prolif. 2025 Apr 26:e70043. doi: 10.1111/cpr.70043.
5
Advances in human induced pluripotent stem cell (hiPSC)-based disease modelling in cardiogenetics.
Med Genet. 2025 Apr 8;37(2):137-146. doi: 10.1515/medgen-2025-2009. eCollection 2025 Jun.
6
Genetic advancements in breast cancer treatment: a review.
Discov Oncol. 2025 Feb 7;16(1):127. doi: 10.1007/s12672-025-01884-x.
7
The cells are all-right: Regulation of the Lefty genes by separate enhancers in mouse embryonic stem cells.
PLoS Genet. 2024 Dec 13;20(12):e1011513. doi: 10.1371/journal.pgen.1011513. eCollection 2024 Dec.
8
A circularly permuted CasRx platform for efficient, site-specific RNA editing.
Nat Biotechnol. 2024 Oct 9. doi: 10.1038/s41587-024-02430-w.
9
Regulation of the cell surface expression of classical and non-classical MHC proteins by the human cytomegalovirus UL40 and rhesus cytomegalovirus Rh67 proteins.
J Virol. 2024 Sep 17;98(9):e0120624. doi: 10.1128/jvi.01206-24. Epub 2024 Aug 29.
10
Engineering single-cycle MeV vector for CRISPR-Cas9 gene editing.
Mol Ther Methods Clin Dev. 2024 Jun 24;32(3):101290. doi: 10.1016/j.omtm.2024.101290. eCollection 2024 Sep 12.
本文引用的文献
1
RNA-programmed genome editing in human cells.
Elife. 2013 Jan 29;2:e00471. doi: 10.7554/eLife.00471.
2
RNA-guided human genome engineering via Cas9.
Science. 2013 Feb 15;339(6121):823-6. doi: 10.1126/science.1232033. Epub 2013 Jan 3.
3
Multiplex genome engineering using CRISPR/Cas systems.
Science. 2013 Feb 15;339(6121):819-23. doi: 10.1126/science.1231143. Epub 2013 Jan 3.
4
A TALEN genome-editing system for generating human stem cell-based disease models.
Cell Stem Cell. 2013 Feb 7;12(2):238-51. doi: 10.1016/j.stem.2012.11.011. Epub 2012 Dec 13.
5
A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.
Science. 2012 Aug 17;337(6096):816-21. doi: 10.1126/science.1225829. Epub 2012 Jun 28.
6
Genetic engineering of human pluripotent cells using TALE nucleases.
Nat Biotechnol. 2011 Jul 7;29(8):731-4. doi: 10.1038/nbt.1927.
7
A TALE nuclease architecture for efficient genome editing.
Nat Biotechnol. 2011 Feb;29(2):143-8. doi: 10.1038/nbt.1755. Epub 2010 Dec 22.
Zotero 插件